Combinations of a GLP1R agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders

The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that compr...

Full description

Saved in:
Bibliographic Details
Main Authors ANDREWS ROBERT CARL, CLARK BRADLEY ALAN, VALCARCE LOPEZ MARIA CARMEN, MJALLI ADNAN M. M, DAVIS STEPHEN THOMAS, QUADA JR. JAMES C, YOKUM THOMAS SCOTT, POLISETTI DHARMA RAO
Format Patent
LanguageEnglish
Published 07.10.2015
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin.
AbstractList The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes, lowering blood glucose, and improving the therapeutic effectiveness of metformin. The invention also provides pharmaceutical compositions that comprise a GLP1R agonist and metformin.
Author VALCARCE LOPEZ MARIA CARMEN
POLISETTI DHARMA RAO
DAVIS STEPHEN THOMAS
ANDREWS ROBERT CARL
QUADA JR. JAMES C
MJALLI ADNAN M. M
CLARK BRADLEY ALAN
YOKUM THOMAS SCOTT
Author_xml – fullname: ANDREWS ROBERT CARL
– fullname: CLARK BRADLEY ALAN
– fullname: VALCARCE LOPEZ MARIA CARMEN
– fullname: MJALLI ADNAN M. M
– fullname: DAVIS STEPHEN THOMAS
– fullname: QUADA JR. JAMES C
– fullname: YOKUM THOMAS SCOTT
– fullname: POLISETTI DHARMA RAO
BookMark eNqNjE0KwlAMhLvQhX93iAcQrC2iSyn-LERE3JfUpvrAl5SXKHh72-IBXM3Mx8wMox4L0yB6Z-ILx2hOWEEqQNgfz_EF8C7s1AC5BE9WSfCOu_RSAntQoKbd4NaDBULzxNZe2KcmWEDpsCAj7UbSLhqkEkoKOo76FT6VJj8dRdPd9podZlRLTlrjjZgsz07xPF0vV0kab5J_Ol-sckX1
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID CN104968341A
GroupedDBID EVB
ID FETCH-epo_espacenet_CN104968341A3
IEDL.DBID EVB
IngestDate Fri Jul 19 13:56:48 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CN104968341A3
Notes Application Number: CN201480004613
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151007&DB=EPODOC&CC=CN&NR=104968341A
ParticipantIDs epo_espacenet_CN104968341A
PublicationCentury 2000
PublicationDate 20151007
PublicationDateYYYYMMDD 2015-10-07
PublicationDate_xml – month: 10
  year: 2015
  text: 20151007
  day: 07
PublicationDecade 2010
PublicationYear 2015
RelatedCompanies TRANS TECH PHARMA LLC
RelatedCompanies_xml – name: TRANS TECH PHARMA LLC
Score 3.0001695
Snippet The present invention provides uses of a glucagon-like peptide 1 receptor agonist in combination with metformin. Uses include treating type 2 diabetes,...
SourceID epo
SourceType Open Access Repository
SubjectTerms HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Combinations of a GLP1R agonist and metformin and use thereof for the treatment of type 2 diabetes and other disorders
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20151007&DB=EPODOC&locale=&CC=CN&NR=104968341A
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4gGvVNUaP4IzUxe1sEVgY8LEY6JjE6CEHDG-najmDiRtzQf99rHeCLvnXddkkvuX531--uADeRKyjndYxN4ti1KRU1m8cittuSdmRN0ZqMDcs3dPsv9HHSnJTgbVULY_qEfpnmiGhRAu09N_v1YpPE8g23MruN5jiV3gVjz7eK6BjhCzHP8rtebzjwB8xizGOhFY70Jbcdt41b9v0WbKMb3dL0r95rV1elLH5DSnAAO0OUluSHUFJJBfbY6ua1Cuw-FwfeOCxsLzuCTzRdDGN_MmwkjQknD0_D-ojwWarb3xKeSPKucu2FzhPztMwU0Q6ewq9xWo_JmlmuRegELGmQVQLW_GRKsogsunJmx3Ad9Masb-MCpmttTVm4WatzAuUkTdQpECUwEJbS4RqVo1Y7cpoub7jKQYdMRFScQfVvOdX_Xp7Dvta8Ybi1LqCcfyzVJSJ1Hl0ZFX8DTDqZpQ
link.rule.ids 230,309,783,888,25578,76884
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3fT8IwEL4gGvFNUYP4qyZmb4vAyhgPxMgGosIgBA1vpGs7g4kbcUP_fa91gC_61nXdJW1z_e5ud18BrgObU8aq6JuEoW1SyismC3loOoI2RUXSigh1lq9v957p47Q-zcHbqhZG84R-aXJE1CiO-p7q83qxCWJ5OrcyuQnm2BXfdictz8i8Y4QvxDzDa7c6o6E3dA3Xbbm-4Y_VJbdN28Ej-24LttHEdhTPfuelrapSFr8hpbsPOyOUFqUHkJNREQru6ua1IuwOsh_e2Mx0LzmET1RddGN_ImwkDgkj9_1RdUzYa6zobwmLBHmXqbJC55F-WiaSKANP4mjsVm2yzixXIlQAltTIKgCrP9IlWURkrJzJEVx1OxO3Z-IEZuvVmrn-Zq7WMeSjOJIlIJKjIyyExRQqBw0nsOo2q9nSQoOMB5SfQPlvOeX_Xl5CoTcZ9Gf9B__pFPbULuhst8YZ5NOPpTxH1E6DC73c36oHnJU
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Combinations+of+a+GLP1R+agonist+and+metformin+and+use+thereof+for+the+treatment+of+type+2+diabetes+and+other+disorders&rft.inventor=ANDREWS+ROBERT+CARL&rft.inventor=CLARK+BRADLEY+ALAN&rft.inventor=VALCARCE+LOPEZ+MARIA+CARMEN&rft.inventor=MJALLI+ADNAN+M.+M&rft.inventor=DAVIS+STEPHEN+THOMAS&rft.inventor=QUADA+JR.+JAMES+C&rft.inventor=YOKUM+THOMAS+SCOTT&rft.inventor=POLISETTI+DHARMA+RAO&rft.date=2015-10-07&rft.externalDBID=A&rft.externalDocID=CN104968341A